CIK 0001404281
- Non-accelerated filer
- Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-10 | Katkin Keith Director | Exercise or conversion | +8,575 | 8,575 | ||
| 2026-01-10 | Katkin Keith Director | Exercise or conversion · Restricted Stock Units | −8,575 | 0 | ||
| 2025-01-10 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +77,175 | 77,175 | ||
| 2025-01-10 | Katkin Keith Director | Grant or award · Restricted Stock Units | +8,575 | 8,575 | ||
| 2023-05-01 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +752,185 | 752,185 | ||
| 2023-02-01 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2022-02-01 | Katkin Keith Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-09-11 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +5,907.15 | 5,907.15 | ||
| 2019-07-11 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-06-13 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +9,100 | 9,100 | ||
| 2017-06-30 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 |
Page 1 of 1 · 11 trades